64 related articles for article (PubMed ID: 22345704)
1. Trend in the number of registrations for neuroblastoma in Japan.
Kawada T
Jpn J Clin Oncol; 2012 Apr; 42(4):357-8. PubMed ID: 22345704
[No Abstract] [Full Text] [Related]
2. Is the mass screening for neuroblastoma ineffective?
Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
[TBL] [Abstract][Full Text] [Related]
3. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
[No Abstract] [Full Text] [Related]
5. Neuroblastoma screening in early life.
Suita S
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12226161
[No Abstract] [Full Text] [Related]
6. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma screening in early life.
Collins MH
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
[No Abstract] [Full Text] [Related]
8. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
9. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastomas that might benefit from mass screening at 6 months of age in Japan.
Kaneko Y
Pediatr Blood Cancer; 2007 Feb; 48(2):245-6; author reply 247. PubMed ID: 16652345
[No Abstract] [Full Text] [Related]
11. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
12. Mass screening for neuroblastoma in infancy. The Japanese Mass Screening Study Group of Neuroblastoma.
Sawada T; Sugimoto T; Matsumura T; Tunoda A; Takeda T; Yamamoto K; Koide R; Nagahara N; Hanawa Y; Nishihira K
Prog Clin Biol Res; 1988; 271():525-34. PubMed ID: 3406016
[No Abstract] [Full Text] [Related]
13. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
14. Screening for neuroblastoma.
Weinblatt M
Pediatrics; 1988 Jan; 81(1):175-7. PubMed ID: 3336591
[No Abstract] [Full Text] [Related]
15. Is neuroblastoma screening evaluation needed and feasible?
Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis neuroblastoma: is screening the answer?
Craft AW; Parker L
Br J Cancer Suppl; 1992 Aug; 18():S96-101. PubMed ID: 1503935
[TBL] [Abstract][Full Text] [Related]
17. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan.
Yamamoto K; Ohta S; Ito E; Hayashi Y; Asami T; Mabuchi O; Higashigawa M; Tanimura M
J Clin Oncol; 2002 Mar; 20(5):1209-14. PubMed ID: 11870162
[TBL] [Abstract][Full Text] [Related]
18. Incidence of neuroblastoma in Sapporo city.
Nishi M; Miyake H; Takeda T; Shimada M; Takasugi N; Sato Y; Hanai J
J Pediatr Surg; 1990 May; 25(5):545-6. PubMed ID: 2191108
[TBL] [Abstract][Full Text] [Related]
19. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
Nishi M; Takeda T; Hatae Y; Hanai J; Fujita K; Ichimiya H; Tanaka T
J Exp Clin Cancer Res; 2002 Mar; 21(1):73-8. PubMed ID: 12071533
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma screening at one year of age.
Schilling FH; Spix C; Berthold F; Erttmann R; Fehse N; Hero B; Klein G; Sander J; Schwarz K; Treuner J; Zorn U; Michaelis J
N Engl J Med; 2002 Apr; 346(14):1047-53. PubMed ID: 11932471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
